Atsena Therapeutics Funding: $158M Raised, Series C (2025)
Atsena Therapeutics is a Biotech company based in Durham, North Carolina. It has raised $158M in total funding. Latest round: Series C.
Atsena Therapeutics funding overview
Atsena Therapeutics is a Biotech company based in Durham, North Carolina. Atsena Therapeutics has raised $158M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2025. The round record for Atsena Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Hatteras Venture Partners, Foundation Fighting Blindness. 2 distinct backers are named across the disclosed rounds.
Atsena Therapeutics at a glance
Total raised
$158M
Latest round
Series C
Latest round date
January 2025
Industry
Biotech
Headquarters
Durham, North Carolina
Notable investors
Hatteras Venture Partners, Foundation Fighting Blindness
Frequently asked about Atsena Therapeutics funding
How much has Atsena Therapeutics raised?
Atsena Therapeutics has raised $158M in total disclosed funding across the rounds on record.
Who has invested in Atsena Therapeutics?
Hatteras Venture Partners, Foundation Fighting Blindness are named among the investors backing Atsena Therapeutics.
What was the latest Atsena Therapeutics funding round?
The most recent disclosed round is a Series C, announced in January 2025.
Where is Atsena Therapeutics based?
Atsena Therapeutics is based in Durham, North Carolina.
What sector does Atsena Therapeutics operate in?
Atsena Therapeutics is tracked under Biotech from Durham, North Carolina, with $158M in disclosed funding.
When did Atsena Therapeutics last raise?
The last disclosed Atsena Therapeutics round closed in January 2025 at Series C.
Totals shown for Atsena Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Durham and the investors behind them below.
